A report into price gouging and unfair pricing practices developed by Professor Allan Fels and initiated by the ACTU has recommended measures to monitor pharmaceutical companies more closely.
Report recommends mandatory reporting of arrangements despite no evidence they exist
February 8, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
Pharmac announces expanded access to three cancer medicines
October 11, 2024 - - Latest News -
Novartis-led partnership says heart health shouldn't be dependent on where you live
October 11, 2024 - - Latest News -
Bondi Junction response must include increased funding and support for severe mental illness
October 11, 2024 - - Latest News -
New report unveils hidden cost of Alzheimer’s disease, with cases to double by 2050
October 10, 2024 - - Latest News -
Amplia Therapeutics CEO shares Prime Minister's Prize for Innovation
October 10, 2024 - - Latest News -
Healthy Bones Australia calls for greater Government commitment to bone health
October 9, 2024 - - Latest News -
TGA approves new indication for Telix’s Illuccix to include patient selection for PSMA-targeted therapy
October 9, 2024 - - Australian Biotech